{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825895998611968.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1053/j.semnuclmed.2011.02.002"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0001299811000316?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0001299811000316?httpAccept=text/plain"}}],"dc:title":[{"@value":"The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825895998611971","@type":"Researcher","foaf:name":[{"@value":"Samuel L. Rice"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895998611969","@type":"Researcher","foaf:name":[{"@value":"Celeste A. Roney"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895998611970","@type":"Researcher","foaf:name":[{"@value":"Pierre Daumar"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895998611968","@type":"Researcher","foaf:name":[{"@value":"Jason S. Lewis"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00012998"}],"prism:publicationName":[{"@value":"Seminars in Nuclear Medicine"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2011-07","prism:volume":"41","prism:number":"4","prism:startingPage":"265","prism:endingPage":"282"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0001299811000316?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0001299811000316?httpAccept=text/plain"}],"createdAt":"2011-06-23","modifiedAt":"2020-06-20","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050001335841173248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706253246592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Synthesis and in vitro evaluation of thiododecaborated α, α- cycloalkylamino acids for the treatment of malignant brain tumors by boron neutron capture therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643921749632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The diagnostic performance of 18F-FAMT PET and 18F-FDG PET for malignancy detection: a meta-analysis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1053/j.semnuclmed.2011.02.002"},{"@type":"CROSSREF","@value":"10.1007/s00726-014-1829-5_references_DOI_KhJ8Z2HckndhnXT0DbYiALvaYA9"},{"@type":"CROSSREF","@value":"10.1186/s13014-017-0765-4_references_DOI_KhJ8Z2HckndhnXT0DbYiALvaYA9"},{"@type":"CROSSREF","@value":"10.1186/s12880-017-0237-1_references_DOI_KhJ8Z2HckndhnXT0DbYiALvaYA9"}]}